<DOC>
	<DOCNO>NCT00421096</DOCNO>
	<brief_summary>The scope trial ass efficacy association gemcitabine-cisplatin + radiotherapy follow adjuvant chemotherapy</brief_summary>
	<brief_title>Radiochemotherapy Followed Adjuvant Chemotherapy Based Gemcitabine Uterine Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Age 18 70 year old Cervical uterine cancer ( epidermoid adenocarcinoma , stage : IB &gt; = 4 cm IV , accord FIGO classification ) histologically prove Measurable lesion , clinically MRI assess PSWHO &lt; = 2 ou Karnofsky Index &gt; 70 per cent Life expectancy &gt; 3 month Hematologic function : leukocyte &lt; = 3 G/l , polynuclear neutrophil leukocytes &gt; = 1.5 G/l , platelets &gt; = 100 G/l , hemoglobin &gt; = 10 g/dl Hepatic function : ASAT ALAT &lt; 2.5 ULN Renal function : creatininemia &lt; 1.5 ULN , clearance &gt; 60 ml/min No prior chemotherapy radiotherapy Contraception Written inform consent sign Stage IB &lt; 4 cm IVB Other histology epidermoid adenocarcinoma Distant metastasis , include susclavicular adenopathy Contraindication MRI Pregnant lactate woman Autoimmune disease Peripheric neuropathy , autograft homograft , psychiatric disease Prior cancer ( except cutaneous basocellular carcinoma uterine cervical carcinoma situ ) Active infection Other clinical trial experimental drug Known positive serology ( HIV , HbC , HbS )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>uterine cervical cancer</keyword>
</DOC>